Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Assets (2019 - 2025)

IDEAYA Biosciences' Assets history spans 7 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Assets fell 1.31% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, down 1.31%, while the annual FY2025 figure was $1.1 billion, 1.31% down from the prior year.
  • Assets for Q4 2025 was $1.1 billion at IDEAYA Biosciences, down from $1.2 billion in the prior quarter.
  • Across five years, Assets topped out at $1.2 billion in Q3 2024 and bottomed at $326.1 million in Q1 2021.
  • The 5-year median for Assets is $530.2 million (2023), against an average of $687.1 million.
  • The largest annual shift saw Assets skyrocketed 220.36% in 2021 before it decreased 4.41% in 2025.
  • A 5-year view of Assets shows it stood at $381.3 million in 2021, then increased by 1.74% to $388.0 million in 2022, then soared by 67.36% to $649.3 million in 2023, then skyrocketed by 73.12% to $1.1 billion in 2024, then decreased by 1.31% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Assets are $1.1 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.0 billion (Q2 2025).